Hence, to date, the correlation between the co-existence of the LMP-1 30-bp deletion and loss of XhoI restriction site variants in either NPC tissue or plasma with clinicopathological data has not yet been studied. The gene discussed is PDLIM7; the disease is nasopharyngeal carcinoma.